Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teresa H Evering

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Current HIV/AIDS Reports|February 21, 2018
Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive DisordersTeresa H Evering
Frontiers in Immunology|April 20, 2018
Human Immune System Mice for the Study of Human Immunodeficiency Virus-Type 1 Infection of the Central Nervous SystemTeresa H Evering, Moriya Tsuji
Expert Opinion on Investigational Drugs|March 7, 2008
Raltegravir: an integrase inhibitor for HIV-1Teresa H Evering, Martin Markowitz
Infectious Disease Clinics of North America|May 31, 2022
Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 InfectionAluko A Hope, Teresa H Evering
Trends in Microbiology|October 16, 2023
Cellular rejuvenation to combat HIV-1-related neurocognitive impairmentPhilipp N Ostermann, Teresa H Evering
Trends in Neurosciences|January 1, 2023
Transposable elements and Alzheimer's disease pathogenesisTeresa H Evering, Jez L Marston, Li Gan, et al.
Journal of Virology|August 8, 2020
Drug Resistance Mutation Frequency of Single-Genome Amplification-Derived HIV-1 Polymerase Genomes in the Cerebrospinal Fluid and Plasma of HIV-1-Infected Individuals under Nonsuppressive TherapyLeslie St Bernard, Jeremy Abolade, Hiroshi Mohri, et al.
AIDS (London, England)|December 20, 2015
Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infectionTeresa H Evering, Allison Applebaum, Melissa La Mar, et al.
Retrovirology|August 16, 2014
Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelopeTeresa H Evering, Edwin Kamau, Leslie St Bernard, et al.
Plos Pathogens|February 10, 2012
Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infectionTeresa H Evering, Saurabh Mehandru, Paul Racz, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Current HIV/AIDS Reports|February 21, 2018
Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive DisordersTeresa H Evering
Frontiers in Immunology|April 20, 2018
Human Immune System Mice for the Study of Human Immunodeficiency Virus-Type 1 Infection of the Central Nervous SystemTeresa H Evering, Moriya Tsuji
Expert Opinion on Investigational Drugs|March 7, 2008
Raltegravir: an integrase inhibitor for HIV-1Teresa H Evering, Martin Markowitz
Infectious Disease Clinics of North America|May 31, 2022
Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 InfectionAluko A Hope, Teresa H Evering
Trends in Microbiology|October 16, 2023
Cellular rejuvenation to combat HIV-1-related neurocognitive impairmentPhilipp N Ostermann, Teresa H Evering
Trends in Neurosciences|January 1, 2023
Transposable elements and Alzheimer's disease pathogenesisTeresa H Evering, Jez L Marston, Li Gan, et al.
Journal of Virology|August 8, 2020
Drug Resistance Mutation Frequency of Single-Genome Amplification-Derived HIV-1 Polymerase Genomes in the Cerebrospinal Fluid and Plasma of HIV-1-Infected Individuals under Nonsuppressive TherapyLeslie St Bernard, Jeremy Abolade, Hiroshi Mohri, et al.
AIDS (London, England)|December 20, 2015
Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infectionTeresa H Evering, Allison Applebaum, Melissa La Mar, et al.
Retrovirology|August 16, 2014
Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelopeTeresa H Evering, Edwin Kamau, Leslie St Bernard, et al.
Plos Pathogens|February 10, 2012
Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infectionTeresa H Evering, Saurabh Mehandru, Paul Racz, et al.
Pageof 4